Blue Logo - RZ_Logo_Immunic_PFADE_1601


Immunic, Inc.

Immunic, Inc. is a clinical-stage biopharmaceutical company with a pipeline of selective oral immunology therapies focused on treating chronic inflammatory and autoimmune diseases. 

Nasdaq: IMUX
IR Website:
Headquarters: New York, NY

Content provided by Immunic, Inc. on 3-3-22.


The Immunic, Inc. management team is always available to talk to current and potential investors. They're happy to answer any questions you may have and tell you what makes their story unique. Please fill out this form, and we will connect you shortly.


Investor Presentation

Management Overview

Risks & Disclosures